Pekin Hardy Strauss Inc. Takes $522,000 Position in Electromed, Inc. (NYSE:ELMD)

Pekin Hardy Strauss Inc. bought a new stake in Electromed, Inc. (NYSE:ELMD) during the second quarter, Holdings Channel reports. The institutional investor bought 34,750 shares of the company’s stock, valued at approximately $522,000.

A number of other institutional investors have also modified their holdings of ELMD. Gamco Investors INC. ET AL grew its position in Electromed by 32.6% in the 1st quarter. Gamco Investors INC. ET AL now owns 111,356 shares of the company’s stock valued at $1,798,000 after buying an additional 27,356 shares during the last quarter. Gabelli Funds LLC grew its position in Electromed by 76.1% in the 1st quarter. Gabelli Funds LLC now owns 35,867 shares of the company’s stock valued at $579,000 after buying an additional 15,500 shares during the last quarter. Morgan Dempsey Capital Management LLC purchased a new position in Electromed in the 2nd quarter valued at $108,000. Vanguard Group Inc. grew its position in Electromed by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 367,114 shares of the company’s stock valued at $5,929,000 after buying an additional 5,886 shares during the last quarter. Finally, Hunter Associates Investment Management LLC grew its position in Electromed by 7.1% in the 1st quarter. Hunter Associates Investment Management LLC now owns 86,200 shares of the company’s stock valued at $1,391,000 after buying an additional 5,700 shares during the last quarter. 40.82% of the stock is owned by institutional investors and hedge funds.

Electromed Price Performance

NYSE:ELMD opened at $19.83 on Wednesday. The firm’s fifty day moving average price is $15.82 and its 200 day moving average price is $15.77. Electromed, Inc. has a 1-year low of $9.53 and a 1-year high of $20.18. The firm has a market cap of $171.65 million, a price-to-earnings ratio of 39.66 and a beta of 0.27.

Electromed (NYSE:ELMD) last posted its quarterly earnings data on Tuesday, August 27th. The company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.06. Electromed had a net margin of 9.41% and a return on equity of 12.44%. The firm had revenue of $14.83 million for the quarter.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.